Latest News

Welcome to the Alfred Research Alliance news hub. To catch up on the news from our Alliance members, please click on the links below:

mRNA funding

Around the Precinct – 16 June 2022

This week, three of our members – Alfred Health, Monash University and Baker Heart and Diabetes Institute – have received significant funding for important mRNA projects aiming to improve treatments for muscular dystrophy, metabolic liver disease in infants and cardiovascular disease. The funding is from the state government’s $2 million mRNA Victoria Research Acceleration Fund,… Read More

Monash Central Clinical School

Around the Precinct – 9 June 2022

Clinical trials on the Alfred precinct have received a funding boost this week, with four Monash researchers receiving a total of $13.6 million in the latest round of the NHMRC Clinical Trials and Cohort Studies Scheme. These trials will enable further research into treatments for debilitating conditions such as diabetes and epilepsy, as well as… Read More

Baker Heart and Diabetes Institute

Around the Precinct – 2 June 2022

This week there is a big focus on diabetes and dementia across the precinct. At the Baker Heart and Diabetes Institute, researchers examined Fitbit data from before and during Melbourne’s 2020 lockdown and noticed a concerning drop in physical activity among people with type 2 diabetes. At Monash University’s Central Clinical School, researchers have published… Read More

Monash REMAP-CAP clinical trial

Around the Precinct – 26 May 2022

In 2019, one in every five Australian clinical trials was commenced or continued here on the Alfred precinct. Three years later we are still one of the leading clinical trial sites in the country, as recognised this week with not one but two awards from the Australian Clinical Trials Alliance (ACTA), including the prestigious Trial… Read More